Readoutin 104d
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — SHR-A1912 Injection
Phase 3 primary completion: A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma.
- Date
- Mar 2027
- Type
- Readout
- Indication
- Diffuse Large B-cell Lymphoma